Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Pleskow, H. [1 ]
Otani, K. [1 ]
Kusaka, E. [1 ]
Ukleja, J. [1 ]
Balza, R. [2 ]
Fisher, R. [1 ]
Broderick, K. [3 ]
Maheswaran, S. [3 ]
Haber, D. [3 ]
Saylor, P. J. [3 ]
Miyamoto, D. T. [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3222
引用
收藏
页码：E534 / E535
页数：2
相关论文
共 50 条
  • [41] Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice
    Prelaj, Arsela
    Rebuzzi, Sara Elena
    Buzzacchino, Federica
    Pozzi, Chiara
    Ferrara, Carla
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Civitelli, Liana
    De Vincentis, Giuseppe
    Tomao, Silverio
    Bianco, Vincenzo
    [J]. ONCOLOGY LETTERS, 2019, 17 (02) : 1467 - 1476
  • [42] DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223
    Ramos, Jorge D.
    Mostaghel, Elahe A.
    Pritchard, Colin C.
    Yu, Evan Y.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 106 - 110
  • [43] Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
    Odo, Ugochukwu
    Vasudevamurthy, Ashwin K.
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E501 - E502
  • [44] Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Clinical Development and Use in Contemporary Practice
    Morgan, Scott C.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2019, 50 (04) : S26 - S30
  • [45] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Marie Øbro Fosbøl
    Peter Meidahl Petersen
    Gedske Daugaard
    Søren Holm
    Andreas Kjaer
    Jann Mortensen
    [J]. Annals of Nuclear Medicine, 2018, 32 : 16 - 21
  • [46] Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer
    Wong, William W.
    Anderson, Eric M.
    Mohammadi, Homan
    Daniels, Thomas B.
    Schild, Steve E.
    Keole, Sameer R.
    Choo, C. Richard
    Tzou, Katherine S.
    Bryce, Alan H.
    Ho, Thai H.
    Quevedo, Fernando J.
    Vora, Sujay A.
    [J]. CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E969 - E975
  • [47] Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer
    Picciotto, Maria
    Franchina, Tindara
    Russo, Alessandro
    Ricciardi, Giuseppina Rosaria Rita
    Provazza, Giusy
    Sava, Serena
    Baldari, Sergio
    Caffo, Orazio
    Adamo, Vincenzo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 899 - 908
  • [48] Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, Marie Obro
    Petersen, Peter Meidahl
    Daugaard, Gedske
    Holm, Soren
    Kjaer, Andreas
    Mortensen, Jann
    [J]. ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 16 - 21
  • [49] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Nilsson, Sten
    [J]. CURRENT ONCOLOGY REPORTS, 2016, 18 (02) : 1 - 12
  • [50] Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
    Sten Nilsson
    [J]. Current Oncology Reports, 2016, 18
12345